Piper Sandler Cuts Align Technology (ALGN) Price Target to $205
Key Points
- Piper Sandler maintained an Overweight rating on Align Technology, Inc. on October 21, 2026, while adjusting its price target down to $205.00 from $235.00.
- Piper Sandler's $205 price target implies 35.43% upside from Align Technology, Inc.'s ($ALGN) current $151.37 share price.
- The medical device maker trades recently around $151.37, positioned below its 50-day moving average ahead of an earnings report slated for October 28, 2026.
- Wall Street maintains a general buy consensus on the stock across 14 analyst opinions, with an average target price of $190.21.
Since the rating, $ALGN is up 2.1% to date (from the $151.37 close on Oct 21, 2026).
Get Align Technology text alerts
We text you when insiders, Congress, analysts or big funds move on $ALGN.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Align Technology, Inc. alert may contain errors. Disclosures
On October 21, 2026, Piper Sandler maintained its Overweight rating on Align Technology, Inc. while adjusting its price target down to $205.00 from $235.00. The update arrived via a research note from the firm on the same day the stock closed at $151.37.
ALGN
Align Technology, Inc.
Piper Sandler vs. the S&P 500
Hypothetical returns from Piper Sandler's disclosed trades, not real profit or advice. How we model this.
Piper Sandler's Call on Align Technology, Inc.
In its October 21, 2026 note, Piper Sandler kept its positive stance on the medical device maker while lowering its twelve-month target by $30.00 to $205.00. Other Wall Street firms have also updated their views recently. On October 5, 2026, Evercore ISI Group downgraded the stock to an In-Line rating and cut its target to $155.00 from $220.00. Stifel kept a Buy rating on October 9, 2026, while lowering its target to $175.00 from $210.00. Leerink Partners maintained an Outperform rating on October 14, 2026, adjusting its target from $235.00 to $215.00. Baird followed on October 15, 2026, with a downgrade to Neutral and a lower target of $162.00.
Other Institutional Activity in Align Technology, Inc.
Capital International Investors grew its holdings by 236,182 shares, ending with 4,045,561 shares worth about $623,683,884 as of June 30, 2026. Ninety One UK Ltd trimmed its stake by 76,240 shares, or 3.5%, leaving it with 2,133,621 shares valued at roughly $328,929,667 on September 30, 2026.
Align Technology, Inc. Stock Holds Steady
Shares closed at $151.37 on October 21, 2026, matching its spot price of $151.37 as of October 22, 2026. The stock trades about 1.0% below its 50-day moving average of $152.88 and sits below its 200-day moving average of $169.40. Align Technology, Inc. carries a market capitalization of roughly $11.0 billion.
$ALGN price target
Align Technology, Inc. daily closes and this analyst's $205 target. Not advice.
Recent Earnings
Align Technology, Inc. reported trailing twelve-month revenue of $4.14 billion and earnings of $5.75 per share. The company generated a net profit margin of 10.0% and a return on equity of 10.2%. Investors await the next financial update scheduled for October 28, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.0%. Revenue met estimates.
-
Profit surprise
EBITDA missed by 36 percent. Operating income missed by 13 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 3.2 points. Positive free cash flow.
Earnings Call Summary
Align reported $1.041 billion in Q1 revenue, up 6.2 percent, with record clear aligner shipments of 686,000 cases. Growth was driven by strong international performance, particularly in EMEA and APAC with double-digit volume increases, while North America remained stable. Management attributed near-term caution to Middle East conflict uncertainty and ongoing macro headwinds affecting consumer demand, but emphasized long-term confidence in digital orthodontics and restorative dentistry expansion through new products like the Invisalign palate expander and treatment planning services.
Guidance Management reaffirmed full year revenue growth of 3 percent to 4 percent and clear aligner volume growth in mid-single digits. They expect Q2 revenue of $1.040 billion to $1.060 billion, up 3 percent to 5 percent year-over-year, with clear aligner volumes up both sequentially and year-over-year.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Align Technology, Inc.
Chief Executive Officer Joseph M. Hogan bought 7,576 shares on August 1, 2025, at an average price of $131.49 for a total value of $996,131. Later, Chief Financial Officer John Morici sold 7,969 shares on February 18, 2026, at an average price of $189.31, totaling $1,508,646.
Analysts Set New Price Targets
Overall, the company holds a consensus buy rating across 14 analyst opinions, with a mean price target of $190.21. Targets range from a high of $215.00 down to $155.00.
About Align Technology, Inc.
Align Technology, Inc. designs and markets medical dental products. Its portfolio includes clear aligners under the Invisalign brand, Vivera retainers, and iTero intraoral scanning systems used by dental professionals in the United States and international markets.
Bottom Line
Piper Sandler's decision to keep its Overweight rating highlights steady confidence even as multiple firms lower their targets. Investors will look to the earnings report on October 28, 2026, for fresh details on device adoption and financial health.
Related Filing Alerts
Source: Piper Sandler's rating change on $ALGN (Oct 21, 2026). Written by software, not financial advice. How we make alerts